R&D Finance Australia: How to Access Your Tax Incentive Refund Before the ATO Pays It

By Alex Knight - Founder and CEO of Advanced, an Australian R&D capital partner that helps founders and startups access their R&D Tax Incentive refund before the ATO pays it out.

‍

R&D finance is a form of non-dilutive funding that lets Australian businesses access their anticipated R&D Tax Incentive refund before the ATO processes their claim. Instead of waiting six to twelve months for the refund to arrive, you draw against it early and repay the facility when the ATO pays out. No equity. No personal guarantees.

The problem it solves is straightforward. You spend on eligible R&D throughout the year. The refund accrues at 43.5 cents for every dollar of eligible spend. But the cash doesn't arrive until after 30 June, after your claim is lodged, and after the ATO processes it. That gap between when you spend and when you get paid back is where R&D finance sits.

Who Qualifies for R&D Finance in Australia

Your business needs to meet two conditions. First, it must be eligible for the R&D Tax Incentive program. Second, it must have eligible R&D expenditure accruing in the current or prior financial year.

For the refundable offset (the one that actually pays cash back rather than reducing a tax bill), your business needs aggregated annual turnover under $20 million. At that threshold, you receive a 43.5% cash refund on eligible R&D spend, regardless of whether your company is profitable.

Eligible R&D spend includes core experimental activities: work that generates new knowledge through systematic investigation. It also covers the costs directly associated with them. Software development, hardware prototyping, clinical trials, field trials, manufacturing process development, and materials research can all qualify, provided the work meets the ATO and AusIndustry's technical uncertainty tests.

R&D finance works across sectors. Advanced has deployed capital to companies in medtech, agritech, software, deep tech, advanced manufacturing, and climate hardware.

How the Calculation Works

This is the part most guides skip. Here's the actual arithmetic.

Say your business spends $600,000 on eligible R&D in the 2025–26 financial year. At the 43.5% refundable offset rate, your anticipated refund is $261,000. Advanced can advance up to 80% of that anticipated refund, giving you $208,800 of working capital before the ATO has processed anything.

That capital is available typically within two business days of approval. When your ATO refund arrives (usually October to December the following year), it repays the facility automatically.

The financing fee is approximately 1.38% per month on the facility. On a $208,800 facility over six months, that's approximately $17,330 in total financing costs. Compare that to the permanent dilution of an equity raise at the same moment, and the economics are usually clear.

The multiplier effect. If you access the anticipated refund early and put that capital back into eligible R&D before 30 June, that additional spend generates its own refundable offset. At 43.5% on $208,800 of reinvested capital, you generate an additional $90,828 in anticipated refund on top of the original claim, before financing costs and subject to eligibility. Early access isn't just a cashflow bridge. It's a mechanism for compounding the program's value.

When R&D Finance Makes Sense

R&D finance is the right tool when you have a timing problem, not a capital problem.

If your business is spending on eligible R&D and the refund is genuinely accruing, the capital already exists. It's just stuck in a future payment. Using equity to bridge a timing gap is expensive and permanent. The dilution stays long after the timing problem resolves.

It makes particular sense at three moments:

Before 30 June, when reinvesting the accessed capital into additional eligible R&D generates its own offset. This is where the flywheel effect is strongest.

Between funding rounds, when a startup has strong R&D spend but doesn't want to bridge at a suppressed valuation. R&D finance provides non-dilutive runway extension without affecting the cap table.

When cash pressure is affecting build decisions: when founders are slowing hiring, delaying equipment purchases, or cutting development sprints because the refund hasn't landed yet. The ATO's timeline shouldn't be setting your build timeline.

When R&D Finance Isn't the Right Fit

This is worth saying plainly, because not every situation calls for it.

If your business doesn't have eligible R&D spend under the RDTI program, there's no refund to advance against. If your aggregated turnover exceeds $20 million, you're accessing the non-refundable offset, which creates a different structure. If your expected refund is very small, the financing fee may not make economic sense relative to the capital accessed.

R&D finance also doesn't replace equity for genuine capital needs. If you need to fund a new market entry, a significant hire, or a product extension that your R&D refund can't cover, that's a capital problem, not a timing problem. The right tool for a capital problem is usually equity.

How the Process Works at Advanced

The process is designed to move fast because the timing gap is the whole point.

You submit basic information about your business and R&D activity, typically in collaboration with your R&D adviser or accountant. Advanced reviews your eligible expenditure and anticipated refund, working alongside your existing adviser to assess the claim. Once approved, capital is in your account within one to two business days.

The facility is repaid when the ATO refund arrives. There are no monthly repayments against your cash position during the facility period.

Rikky Burkett, Founder of Black6, described their experience this way:

"Advanced has been an incredible partner. Their funding came at critical times, not only helping us survive but letting us move faster. What sets Advanced apart is that they actually take the time to understand your story, not just your spreadsheet. That's rare."

The Difference Between R&D Finance and a Standard Business Loan

A standard business loan is assessed against assets, revenue history, and creditworthiness. Pre-revenue startups rarely qualify. When they do, the terms reflect the risk.

R&D finance is assessed against the anticipated refund. The underlying security is the government's commitment to pay back eligible R&D expenditure, not your company's trading history. That's why it's accessible to companies that traditional lenders won't touch: pre-revenue businesses, companies with no physical assets, and founders who've kept the cap table clean by avoiding debt covenants.

It's also why the structure is different. A business loan stays on the balance sheet until it's fully repaid. An R&D facility is repaid in a single payment when the ATO refund lands, often with no outstanding balance by the time investors see your next set of accounts.